A short plasma exchange protocol is effective in severe myasthenia gravis

[1]  R. Mantegazza,et al.  Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis , 1988, Journal of Neurology.

[2]  M. Marconi,et al.  Single Donor Plasma in Therapeutic Plasma Exchange for Myasthenia Gravis , 1987, The International journal of artificial organs.

[3]  The utility of therapeutic plasmapheresis for neurological disorders. , 1986, National Institutes of Health consensus development conference consensus statement.

[4]  J. Aarli,et al.  Plasma exchange in myasthenia gravis: clinical effect , 1985, Acta neurologica Scandinavica.

[5]  P. Dau.  Plasmapheresis. Therapeutic or experimental procedure? , 1984, Archives of neurology.

[6]  R. Lisak.  Plasma exchange in neurologic diseases. , 1984, Archives of neurology.

[7]  R. Mantegazza,et al.  New antigen for antibody detect ion in myasthenia gravis , 1984, Neurology.

[8]  R. Mantegazza,et al.  Myasthenia gravis , 1984, Neurology.

[9]  A. Acedo,et al.  [Plasmapheresis in the treatment of myasthenia gravis]. , 1983, Revista clinica espanola.

[10]  M. Valbonesi,et al.  Plasma Exchange in Neurological Diseases: A Critical Approach , 1983, Vox sanguinis.

[11]  H. Milner-Brown,et al.  Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis , 1982, Journal of the Neurological Sciences.

[12]  R. Hughes,et al.  Neutrophil Adherence during Hemoperfusion in Fulminant Hepatic Failure , 1982, The International journal of artificial organs.

[13]  R. Lovelace,et al.  EFFECT OF PLASMAPHERESIS IN MYASTHENIA GRAVIS 1978‐1980 * , 1981, Annals of the New York Academy of Sciences.

[14]  P. Dau.  RESPONSE TO PLASMAPHERESIS AND IMMUNOSUPPRESSIVE DRUG THERAPY IN SIXTY MY ASTHENIA GRAVIS PATIENTS * , 1981, Annals of the New York Academy of Sciences.

[15]  C. E. Huggins,et al.  EFFELCT OF PLASMAPHERESIS IN MYASTHENIA GRAVIS , 1981, Annals of the New York Academy of Sciences.

[16]  W. Ho,et al.  PLASMA EXCHANGE ALONE AS THERAPY FOR MY ASTHENIA GRAVIS * , 1981, Annals of the New York Academy of Sciences.

[17]  M. Marconi,et al.  Approaching Plasma-exchange Mathematically , 1981, The International journal of artificial organs.

[18]  T. Mittag,et al.  Plasmapheresis in refractory generalized myasthenia gravis. , 1981, Archives of neurology.

[19]  C. Hawkey,et al.  Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[20]  Miller Rg,et al.  Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange. , 1981 .

[21]  H. Milner-Brown,et al.  Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange. , 1981, Muscle & nerve.

[22]  P. Dau.  Plasmapheresis therapy in myasthenia gravis , 1980, Muscle & nerve.

[23]  G. Lunt,et al.  Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[24]  A. Vincent,et al.  COMBINED PLASMA EXCHANGE AND IMMUNOSUPPRESSION IN MYASTHENIA GRAVIS , 1979, The Lancet.

[25]  A. Papatestas,et al.  PLASMAPHERESIS IN MYASTHENIA GRAVIS: CONTROLLED STUDY , 1979, The Lancet.

[26]  J. Simpson,et al.  PLASMA-EXCHANGE COMBINED WITH IMMUNOSUPPRESSIVE THERAPY IN MYASTHENIA GRAVIS , 1979, The Lancet.

[27]  A. Vincent,et al.  LONG-TERM EFFECTS OF REPEATED PLASMA EXCHANGE IN MYASTHENIA GRAVIS , 1979, The Lancet.

[28]  J. Newsom-Davis,et al.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis , 1978, Neurology.

[29]  J. Lindstrom,et al.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. , 1977, The New England journal of medicine.

[30]  J. Davis,et al.  REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGE , 1976, The Lancet.

[31]  G. Genkins,et al.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. , 1971, The Mount Sinai journal of medicine, New York.